Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Azar nomination

This article was originally published in The Tan Sheet

Executive Summary

HHS General Counsel Alex Azar will testify before the Senate Finance Committee at a May 24 hearing on his nomination for the post of HHS Deputy Secretary. Other HHS posts under consideration include Suzanne DeFrancis for Assistant Secretary for Public Affairs and Charles Johnson for Assistant Secretary for Budget, Technology & Finance...

You may also be interested in...



HHS nominees

A vote to approve the nomination of Alex Azar as HHS Deputy Secretary passed the Senate Finance Committee unanimously July 20. Azar has served as HHS General Counsel since June 2001. Also unanimously approved by the committee were Charles Johnson, nominated as HHS Assistant Secretary for Budget, Technology & Finance and Suzanne DeFrancis for Assistant Secretary for Public Affairs. All three nominees testified before the committee May 24 (1"The Tan Sheet" May 23, 2005, In Brief)...

Cosmetic And Personal Care Trademark Review: 9 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel